Description
Cefralek-D Injection contains Cefoperazone 1 g and Sulbactam 500 mg, a combination antibiotic formulation used for the treatment of various bacterial infections caused by susceptible microorganisms. Cefoperazone is a third-generation cephalosporin antibiotic that works by inhibiting bacterial cell wall synthesis, while Sulbactam helps inhibit beta-lactamase enzymes produced by certain bacteria, enhancing the antibacterial activity of Cefoperazone. Cefralek-D may be prescribed for selected infections affecting the respiratory tract, urinary tract, abdomen, skin and soft tissues, and other areas based on clinical assessment and bacterial susceptibility. It is intended for administration by a qualified healthcare professional under medical supervision. The dosage and duration depend on the type and severity of infection and the patient’s clinical condition. It is not effective against viral infections.
